SCHEMBL6203919

SCHEMBL6203919

COC([O])Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.55
TSHR P16473 3/20 0.53
IDO1 P14902 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
TACR1 P25103 1/20 0.41
SIGMAR1 Q99720 4/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
APEX1 P27695 1/20 0.39
HPGD P15428 1/20 0.39
KCNH2 Q12809 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27606231 0.86 PNMT (0.40) PNMTTSHRSMN1; SMN2TACR1MEN1
SCHEMBL6203922 0.78 PNMT (0.55) PNMTTSHRIDO1SMN1; SMN2TAAR1
SCHEMBL6203635 0.76 PNMT (0.58) PNMTTSHRIDO1TAAR1APEX1
SCHEMBL6006682 0.76 PPARA (0.56) PNMTTSHRSMN1; SMN2TACR1
SCHEMBL6204802 0.76 MEN1 (0.40) SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL28739467 0.75 TSHR (0.54) PNMTTSHRSMN1; SMN2LMNATACR1
SCHEMBL6205215 0.75 IDO1 (0.39) PNMTTSHRIDO1TACR1
SCHEMBL6203594 0.74 MAOA (0.40)
SCHEMBL5018935 0.74 PNMT (0.70) PNMTTSHRIDO1TAAR1SIGMAR1
SCHEMBL14033316 0.74 TSHR (0.57) PNMTTSHRSMN1; SMN2LMNATACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed